Patents by Inventor Hsun-Shuo Chang

Hsun-Shuo Chang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Application for (2R, 4R)-1,2,4-trihydroxyheptadec-16-yne in preparation of pharmaceutical composition for preventing or treating hepatic injury
    Patent number: 11413254
    Abstract: The present invention provides a use of (2R,4R)-1,2,4-trihydroxy heptadec-16-yne or a pharmaceutically acceptable salt, a tautomer, a stereoisomer or an enantiomer thereof in the preparation of a pharmaceutical composition for preventing or treating liver injury.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: August 16, 2022
    Assignee: NORBEL BABY CO., LTD.
    Inventors: Jin-Ching Lee, Hsun-Shuo Chang, Ih-Sheng Chen, Chin-Kai Tseng, Chun-Kuang Lin
  • APPLICATION FOR (2R, 4R)-1,2,4-TRIHYDROXYHEPTADEC-16-YNE IN PREPARATION OF PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATIC INJURY
    Publication number: 20200230075
    Abstract: The present invention provides a use of (2R,4R)-1,2,4-trihydroxy heptadec-16-yne or a pharmaceutically acceptable salt, a tautomer, a stereoisomer or an enantiomer thereof in the preparation of a pharmaceutical composition for preventing or treating liver injury.
    Type: Application
    Filed: December 22, 2016
    Publication date: July 23, 2020
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Jin-Ching Lee, Hsun-Shuo Chang, Ih-Sheng Chen, Chin-Kai Tseng, Chun-Kuang Lin
  • Methods for treating angiogenesis related disorder
    Patent number: 10561637
    Abstract: A method of treating a subject suffering from an angiogenesis-related disease, which is implemented by administering to the subject a pharmaceutical composition comprising a compound of formula I derived from Mitella formosana to inhibit the angiogenic function of endothelial progenitor cells.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: February 18, 2020
    Assignee: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Hsun-Shuo Chang, Ih-Sheng Chen, Chien-Jou Peng, Shih-Wei Wang, Chih-Hsin Tang
  • METHODS FOR TREATING ANGIOGENESIS RELATED DISORDER
    Publication number: 20180353467
    Abstract: A method of treating a subject suffering from an angiogenesis-related disease, which is implemented by administering to the subject a pharmaceutical composition comprising a compound of formula I derived from Mitella formosana to inhibit the angiogenic function of endothelial progenitor cells.
    Type: Application
    Filed: February 27, 2018
    Publication date: December 13, 2018
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Hsun-Shuo Chang, Ih-Sheng Chen, Chien-Jou Peng, Shih-Wei Wang, Chih-Hsin Tang
  • Bioactivity composition of
    Patent number: 8658605
    Abstract: A series cardenolide derivatives including structure of formula I from the root of Reevesia formosana have provided. In formula (1) and (2), where R3, R5, R10 and R16 are as defined in the specification. The derivatives compounds showed potent cytotoxicity against MCF-7, NCI-H460, and HepG2 cancer cell lines.
    Type: Grant
    Filed: October 4, 2011
    Date of Patent: February 25, 2014
    Assignee: Kaohsiung Medical University
    Inventors: Ih-Sheng Chen, Hsun-Shuo Chang
  • BIOACTIVITY COMPOSITION OF Reevesia formosana
    Publication number: 20120258923
    Abstract: A series cardenolide derivatives including structure of formula I from the root of Reevesia formosana have provided. In formula (1) and (2), where R3, R5, R10 and R16 are as defined in the specification. The derivatives compounds showed potent cytotoxicity against MCF-7, NCI-H460, and HepG2 cancer cell lines.
    Type: Application
    Filed: October 4, 2011
    Publication date: October 11, 2012
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Ih-Sheng Chen, Hsun-Shuo Chang